Egetis Therapeutics
Business Services · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Klara Norra Kyrkogata 26, Stockholm, Sto...Phone Number
+46 86797210Website
www.egetis.comRevenue
$6 MillionStock Symbol
EGTXIndustry
About Egetis Therapeutics
Is Egetis Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Egetis Therapeutics has new funding data
Check if Egetis Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Egetis Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Egetis Therapeutics
Earning: See what the market has to say on Egetis Therapeutics recently announced quarterly report
Egetis Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Egetis Therapeutics is spiking on competitors!
Click to see if Egetis Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Egetis Therapeutics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Egetis Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Egetis Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Egetis Therapeutics.
Egetis Therapeutics financials insights
Gather financial insights about Egetis Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$26.5M
Share Placement
$15.7M
Egetis Therapeutics Tech Stack
A closer look at the technologies used by Egetis Therapeutics
Most Recent Scoops
Egetis Therapeutics News & Media
Egetis recruits Laetitia Szaller as General Counsel and Head of Compliance
Stockholm, Sweden, December 22, 2023. Egetis Therapeutics AB today announced the recruitment of Laetitia Szaller as General Counsel and Head of Compliance. Laetitia will be a member of the...Egetis Therapeutics AB's Equity Private Placement and Debt Financing
Vinge advised Egetis Therapeutics AB on the deal. Egetis Therapeutics AB (publ), an innovative and integrated pharmaceutical company focusing on projects in late-stage development for commercialization …Egetis Therapeutics has secured approximately SEK 462 million in a combined financing ...
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, ISRAEL, JAPAN, NEW ZEALAND, SOUTH...Egetis Therapeutics asks for hugs to increase disease awareness of MCT8 deficiency
STOCKHOLM, Feb. 24, 2022 /PRNewswire/ -- Egetis Therapeutics AB (publ) (Nasdaq Stockholm: EGTX) today launched #MCT8Hugs – a global, online initiative to drive awareness of MCT8 deficiency. MCT8 deficiency is a rare and life-shortening genetic disease, causing serious consequences such as...
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Egetis Therapeutics
Egetis is an innovative, unique and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment.... Read More